Inscrivez-vous pour créer des alertes relatives aux instruments,
aux événements économiques et au contenu publié par vos auteurs préférés
Inscription gratuite Vous avez déjà un compte ? Connexion
12,410
-0,040
-0,32%
Cotations
Tous types d’instruments
- Tous types d’instruments
- Indices
- Actions
- ETF
- Fonds
- Mat. prem.
- Devises
- Crypto
- Oblig.
- Certificats
Merci d'essayer une autre recherche
⚠ Recul ou correction du marché ? Quoi qu'il en soit, voici ce qu'il faut faire ensuite
Voir Actions Surévaluées
Blackrock Global Funds - World Healthscience Fund A4 Inc (0P0001J98Y)
Ajouter au/Supprimer du portefeuille
Ajout au Portefeuille
20/12 - En Différé. Devise en USD
- Rating de Morningstar:
- Actif total: 729,2M
Type:
Fonds
Marché:
Luxembourg
Emetteur:
BlackRock (Luxembourg) SA
ISIN:
LU2112291526
Catégorie d'actif:
Action
BlackRock Global Funds - World Healthscience Fund
12,410
-0,040
-0,32%
Vue d'ensemble 0P0001J98Y
Sur cette page vous trouverez un profil détaillé de Blackrock Global Funds - World Healthscience Fund A4 Inc. Vous y trouverez notamment des informations sur la gestion, le total des actifs, la stratégie d'investissement et les coordonnées de 0P0001J98Y entre autres informations.
Stratégie d’investissement
Le Compartiment World Healthscience Fund vise à une valorisation optimale du rendement global. Le Compartiment investit à l’échelle mondiale au moins 70 % du total de son actif dans des actions de sociétés exerçant la majeure partie de leurs activités économiques dans les secteurs de la santé, des produits pharmaceutiques, des technologies et fournitures médicales et du développement des biotechnologies. Le risque de change est géré de manière flexible.
Contact
Adresse
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
Téléphone
+44 20 77433000
Fax
Amsterdam
Principaux dirigeants
| Nom | Titre | Depuis | Jusqu’à |
|---|---|---|---|
| Xiang Liu | Director | 2020 | Maintenant |
| Biographie | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | Maintenant |
| Biographie | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| Biographie | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| Biographie | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
Exprimez-vous à propos de Blackrock Global Funds - World Healthscience Fund A4 Inc
Êtes-vous sûr de vouloir supprimer ce graphique ?
Supprimer Annuler
Remplacer le graphique actuel par un nouveau graphique?
Remplacer Annuler
Charte de discussion
Ajouter un graphique au commentaire
Confirmer le blocage
Voulez-vous vraiment bloquer %USER_NAME% ?
Si vous continuez, vous et %USER_NAME% ne verrez plus vos publications Investing.com mutuelles.
%USER_NAME% a bien été ajouté à votre Liste d’utilisateurs bloqués
Vous venez de débloquer cette personne et devrez attendre 48 heures avant de la bloquer de nouveau.
Signaler ce commentaire comme inapproprié
Je souhaite signaler ce commentaire comme:
Commentaire signalé
Merci
Le commentaire signalé sera révisé par nos modérateurs